ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...

… but our independent journalism isn’t free to produce. Help us keep it this way with a tax-deductible donation today. Five years ago, Nancy Skoog-Edholm had no idea that she had two brain aneurysms.

For the new study, Dr. Adeeb and colleagues compared the WEB device in bifurcation and sidewall aneurysms using a large database spanning more than 10 years from the WorldWideWEB consortium, a group ...

Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.

The WEB device has proven clinical data, supported by seven global Good Clinical Practice (GCP) studies 2-8 and over 200 peer-reviewed publications. Over the past 15 years, this revolutionary ...